COVID-19 vaccines (CoronaVac) available now

Our Outpatient Department, Matilda Medical Centre in Central and Matilda Clinic – Caine Road are now offering vaccination service of CoronaVac (Sinovac) for priority groups. You can book directly with us for the vaccination. The COVID-19 vaccination fee is FREE.

Call our us or book an appointment online.

Matilda International Hospital
t 2849 0111
このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。

Matilda Medical Centre (Central)
t 2537 8500
このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。 

Matilda Clinic – Caine Road
t 2849 2216
このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。

What should I expect after making an online booking?

Our clinic will give you a call for the appointment date and time.
Please read the following information before you come for the vaccination. 

After vaccination, you will receive a paper vaccination record. Alternatively, you can also download the electronic vaccination record via the "iAM Smart" mobile app, or through the “eHealth” mobile app.

To register with the eHealth (Electronic Health Record Sharing System), click here to follow the instruction.

Why do I need a COVID-19 vaccination?

The Coronavirus Disease 2019 (COVID-19) is a pandemic which arose at the end of 2019. COVID-19 is highly contagious and has spread rapidly in Hong Kong as well as in other areas of the world. Patients infected with COVID-19 may be asymptomatic or symptomatic with symptoms ranging from mild disease such as fever, coughs, loss of smell and loss of taste to severe diseases, to name a few, pneumonia, respiratory failure and death. Currently in Hong Kong, the number of daily COVID-19 cases has been fluctuated with little sign of lowering it to zero infection. The introduction of COVID-19 vaccines is considered the most promising approach for curbing the pandemic in Hong Kong and around the world.

 

What types of COVID-19 vaccines are supplied in Hong Kong?

The COVID-19 vaccination programme rolled out in Hong Kong in February, starting with the supply of CoronaVac inactivated vaccine (Sinovac), followed by Comirnaty mRNA vaccine (Fosun/BioNTech) in March. A third vaccine developed by AstraZeneca is expected to be available in the third quarter this year.

Provider

  

Sinovac

  

Fosun / BioNTech

   

AstraZeneca

Vaccine name

 

CoronaVac  

 

Comirnaty

 

AZD1222

Vaccine type

 

Inactivated vaccine

 

mRNA vaccine

 

Viral vector vaccine

Age group

 

18 and above*

 

16 and above

 

18 and above

Effectiveness(combined efficacy from various clinical trials)

 

62.3%

 

95%

 

70.4% (62.1% with 2 doses regimen, 90% with 1.5 dose regimen) 

Dosing schedule

 

2 doses; 28 days apart

 

2 doses; 21 days apart

 

2 doses; 4 to 12 weeks apart

Common side effects

 

Pain at injection site, headache, tiredness

 

Pain and swelling at injection site, tiredness, headache, muscle and joint pain, chills and fever

 

Local reaction, tiredness, headache, muscle pain

Method of distribution

 
  • Community vaccination centres  
  • General Outpatient Clinics of the Hospital Authority  
  • Private hospitals and clinics – booking details for Matilda Hospital and Clinics to be announced  
 

Community vaccination centres

 

To be announced

*People aged 60 and above

The benefit of using CoronaVac generally exceeds the risk of not using any vaccines in persons aged 60 and above. Phase I and II data on individuals aged 60 and above showed that the vaccine is safe and immunogenic. There is limited phase III efficacy data for individuals aged 60 and above because of small sample size.’

Eligible persons who would like to have a BioNTech vaccination can make a booking through the Government booking system.

For further information, please visit https://www.covidvaccine.gov.hk/en/

To learn more about COVID-19 vaccines, Click here to read the patient information.

Reference

  1. Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong. (2021). Accessed 17 February 2021, Available at https://www.chp.gov.hk/files/pdf/consensus_interim_recommendations_on_the_use_of_covid19_vaccines_inhk.pdf
  2. McIntosh K. (2021). Coronavirus Disease 19 (COVID-19): Clinical Features, UpToDate. Accessed 19 February 2021
  3. Edwards K, Orenstein W. (2021). Coronavirus disease 2019 (COVID-19): Vaccines to prevent SARS-CoV-2 infection, UpToDate. Accessed 3 March 2021
  4. Report on Evaluation of Safety, Efficacy and Quality of CoronaVac COVID-19 Vaccine (Vero Cell) Inactivated. (2021). Accessed 3 March 2021, Available at https://www.fhb.gov.hk/download/our_work/health/201200/e_evaluation_report_CoronaVac.pdf
  5. Report on Evaluation of Safety, Efficacy and Quality of Comirnaty COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection. (2021). Accessed 3 March 2021. Available at https://www.fhb.gov.hk/download/our_work/health/201200/e_evaluation_report.pdf